Treatment of hepatitis delta chronic infection: HBs antigen quantification may help monitoring, and HBs antigen seroconversion could be the ideal 'end' point of treatment

J Clin Virol. 2012 Sep;55(1):83-4. doi: 10.1016/j.jcv.2012.05.015. Epub 2012 Jun 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage*
  • DNA, Viral / blood
  • DNA, Viral / immunology
  • Hepatitis B / immunology
  • Hepatitis B / virology*
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis D, Chronic / drug therapy*
  • Hepatitis D, Chronic / immunology*
  • Hepatitis D, Chronic / virology
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral / blood
  • RNA, Viral / immunology

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • RNA, Viral